Cargando…

Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs

Background. The use of prostate-specific antigen test has markedly increased in Danish general practice in the last decade. Despite the national guidelines advice against PSA screening, opportunistic screening is supposed to be the primary reason for this increased number of PSA tests performed. Aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Jessen, Kasper, Søndergaard, Jens, Larsen, Pia Veldt, Thomsen, Janus Laust
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852312/
https://www.ncbi.nlm.nih.gov/pubmed/24349779
http://dx.doi.org/10.1155/2013/540707
_version_ 1782478647811112960
author Jessen, Kasper
Søndergaard, Jens
Larsen, Pia Veldt
Thomsen, Janus Laust
author_facet Jessen, Kasper
Søndergaard, Jens
Larsen, Pia Veldt
Thomsen, Janus Laust
author_sort Jessen, Kasper
collection PubMed
description Background. The use of prostate-specific antigen test has markedly increased in Danish general practice in the last decade. Despite the national guidelines advice against PSA screening, opportunistic screening is supposed to be the primary reason for this increased number of PSA tests performed. Aims. Based on the increase in the amount of PSA conducted, we aimed to analyse how GPs in Denmark use the PSA test. Methods. A self-administrated questionnaire concerning symptomatic and asymptomatic patient cases was developed based on the national and international guidelines and the extensive literature review, and an in-depth interview conducted with a GP was performed. Results. None of the GPs would do a PSA measurement for an asymptomatic 76-year-old man. For asymptomatic 55- and 42-year-old men, respectively, 21.9% and 18.6% of GPs would measure PSA. Patient request and concern could be potential reasons for measuring PSA for asymptomatic patients. Almost all GPs stated that a PSA measurement is indicated for symptomatic 49- and 78-year-old men, respectively, 98.9% and 93.8%. Conclusion. Opportunistic PC screening is being performed in general practice to a high degree. Hence, current guidelines are not followed, and intense focus should be on more effective implementation strategies in order to avoid overuse of PSA.
format Online
Article
Text
id pubmed-3852312
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-38523122013-12-16 Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs Jessen, Kasper Søndergaard, Jens Larsen, Pia Veldt Thomsen, Janus Laust Int J Family Med Research Article Background. The use of prostate-specific antigen test has markedly increased in Danish general practice in the last decade. Despite the national guidelines advice against PSA screening, opportunistic screening is supposed to be the primary reason for this increased number of PSA tests performed. Aims. Based on the increase in the amount of PSA conducted, we aimed to analyse how GPs in Denmark use the PSA test. Methods. A self-administrated questionnaire concerning symptomatic and asymptomatic patient cases was developed based on the national and international guidelines and the extensive literature review, and an in-depth interview conducted with a GP was performed. Results. None of the GPs would do a PSA measurement for an asymptomatic 76-year-old man. For asymptomatic 55- and 42-year-old men, respectively, 21.9% and 18.6% of GPs would measure PSA. Patient request and concern could be potential reasons for measuring PSA for asymptomatic patients. Almost all GPs stated that a PSA measurement is indicated for symptomatic 49- and 78-year-old men, respectively, 98.9% and 93.8%. Conclusion. Opportunistic PC screening is being performed in general practice to a high degree. Hence, current guidelines are not followed, and intense focus should be on more effective implementation strategies in order to avoid overuse of PSA. Hindawi Publishing Corporation 2013 2013-11-19 /pmc/articles/PMC3852312/ /pubmed/24349779 http://dx.doi.org/10.1155/2013/540707 Text en Copyright © 2013 Kasper Jessen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jessen, Kasper
Søndergaard, Jens
Larsen, Pia Veldt
Thomsen, Janus Laust
Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs
title Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs
title_full Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs
title_fullStr Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs
title_full_unstemmed Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs
title_short Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs
title_sort danish general practitioners' use of prostate-specific antigen in opportunistic screening for prostate cancer: a survey comprising 174 gps
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852312/
https://www.ncbi.nlm.nih.gov/pubmed/24349779
http://dx.doi.org/10.1155/2013/540707
work_keys_str_mv AT jessenkasper danishgeneralpractitionersuseofprostatespecificantigeninopportunisticscreeningforprostatecancerasurveycomprising174gps
AT søndergaardjens danishgeneralpractitionersuseofprostatespecificantigeninopportunisticscreeningforprostatecancerasurveycomprising174gps
AT larsenpiaveldt danishgeneralpractitionersuseofprostatespecificantigeninopportunisticscreeningforprostatecancerasurveycomprising174gps
AT thomsenjanuslaust danishgeneralpractitionersuseofprostatespecificantigeninopportunisticscreeningforprostatecancerasurveycomprising174gps